JDRF Blog

Latest in Conference

  • JDRF Beta Cell Replacement Consortium: Partnerships and Paradigm Shifts

    November 27, 2019

    Last week’s JDRF Beta Cell Replacement Consortium enabled 57 researchers the chance to collaborate in ways that help move research forward more...

  • JDRF Clinical Trial Results Announced at the 55th EASD Meeting

    September 18, 2019

    A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body. If blood glucose levels are...

  • JDRF Hosts 3D Bioprinting Workshop for Type 1 Diabetes

    August 12, 2019

    “The final results should be more mature ‘cellular products’ for beta cell replacement as a functional cure for T1D.” Francesca Spagnoli, Ph.D.,...

  • At ADA, JDRF-Funded Research Takes Center Stage

    June 17, 2019

    JDRF was there when the top type 1 diabetes (T1D) experts from all over the world convened this month at the American...

  • ADA Scientific Sessions Recap—Day #5: Marlon Pragnell, Ph.D.

    June 12, 2019

    The ADA’s Scientific Sessions is completed! Here, with the post-day recap, is Marlon Pragnell, Ph.D., head of the complications program at JDRF,...

  • ADA Scientific Sessions Recap—Day #4: Simi Ahmed, Ph.D.

    June 11, 2019

    The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the immunotherapy program...

  • ADA Scientific Sessions Recap—Day #3.5: Jessica Dunne, Ph.D.

    June 10, 2019

    There was some really exciting prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne,...